Crescentis Capital Limited Board Meeting Scheduled for February 13, 2026 to Consider Q3FY26 Unaudited Financial Results
Crescentis Capital Limited has scheduled a board meeting for February 13, 2026, to consider Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting will also address CCL ESOS 2025 terms through the Nomination and Remuneration Committee. The company has implemented a trading window closure from January 1, 2026, until 48 hours after results publication, ensuring compliance with SEBI insider trading regulations.

*this image is generated using AI for illustrative purposes only.
Crescentis Capital Limited (formerly known as Som Datt Finance Corporation Limited) has informed BSE Limited about its upcoming board meeting scheduled for February 13, 2026. The announcement was made through a regulatory filing dated February 7, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board Meeting Agenda
The board meeting will address several key agenda items as outlined in the company's communication to the stock exchange:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Consider and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2025 |
| ESOS Terms: | Approve terms and conditions of CCL ESOS 2025 by Nomination and Remuneration Committee |
| Other Business: | Transact any other business with Chair's permission |
Regulatory Compliance and Trading Window
The company has implemented strict compliance measures in accordance with SEBI regulations. Under the company's code of conduct for insider trading, adopted pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, specific trading restrictions have been put in place.
The trading window for dealing in company securities by Designated Persons and their immediate relatives has been closed since January 1, 2026. This closure will remain in effect until 48 hours after the financial results are made public, ensuring compliance with insider trading prevention measures.
ESOS Committee Structure
The board will consider the CCL ESOS 2025 terms through its Nomination and Remuneration Committee, which functions as the compensation committee under Regulation 5 read with Part B of Schedule-I of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Company Information
Crescentis Capital Limited, with CIN L65921TS1993PLC188494, is listed on BSE with scrip code 511571. The company is headquartered in Hyderabad and operates under the regulatory oversight of SEBI through various compliance requirements including regular financial disclosures and corporate governance norms.
Historical Stock Returns for Som Datt Finance Corporation
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.67% | +4.30% | -9.58% | -24.33% | +13.56% | +1,150.00% |




























